Delivery Order SPE2DB22D1017-SPE2DB25FG9AP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,622.99 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitive award, issued under a firm fixed-price delivery order contract type with no set-aside designation, represents a pharmaceutical supply requirement for federal medical procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,701.62 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication, on September 2, 2025, with completion by September 3, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract utilizing AmerisourceBergen's existing indefinite delivery vehicle with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,000.64 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,654.77 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by September 15, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio....
- The Defense Logistics Agency awarded a delivery order valued at $27,153.26 to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication. The contract, effective August 5, 2025, with a completion date of August 6, 2025, is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,546.74 to AmerisourceBergen Drug Corp for 30 tablets of Januvia 50 mg on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Januvia 50 mg tablets (90-count) valued at $1,122.26 under a firm fixed price contract. This delivery order, issued on August 27, 2025, with completion scheduled for August 28, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was made through competitive procurement with no set-aside designation, and the product will be delivered to the...
- The Defense Logistics Agency awarded a $2,182.92 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes medication, on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price contract requires delivery to Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. No set-aside designation was applied to this award, demonstrating that AmerisourceBergen competed openly for the...
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9APDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,546.74 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 50 mg, a pharmaceutical product used in diabetes management. The contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is classified as a child contract, indicating it falls under a larger indefinite delivery contract vehicle. This award is executed under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive pharmaceutical support vehicle enabling the distributor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's role as a critical pharmaceutical vendor for federal medical procurement is reinforced through its consistent receipt of competitively awarded contracts across multiple therapeutic domains, positioning the company to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/6/25 |